Analysis of cardiac toxicity caused by cyclophosphamide in the H9c2 cell line and isolated and perfused rat hearts

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 4, 2010, Pages 677-680

  Nakamura, Seiji ^a   Aoki, Manahito ^a   Mori, Asami ^a   Nakahara, Tsutomu ^a   Sakamoto, Kenji ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Acrolein; Cardiac toxicity; Cyclophosphamide

Indexed keywords

ACROLEIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MESNA;

ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL LINE; CELL STRAIN H9C2; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HEART RATE; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN CELL; ISOLATED HEART; NONHUMAN; RAT;

EID: 79960807944     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Federman DG and Henry G: Chemotherapy-induced myocardial necrosis in a patient with chronic lymphocytic leukemia. Respir Med 91(9):565-567, 1997. (Pubitemid 27397300)
2. Wagner T and Ehninger G: Self-induction of cyclophosphamide and ifosfamide metabolism by repeated high-dose treatment. Contr Oncol 26:69-75, 1987.
3. Mosmann T: Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55-63, 1983.
4. Klastersky J: Side effects of ifosfamide. Oncology 65(Suppl 2):7-10, 2003.
5. Brock N: Comparative pharmacologic study in vitro and in vivo with cyclophosphamide, cyclophosphamide metabolites, and plain nitrogen mustard compounds. Cancer Treat Rep 60:301-308, 1976.
6. Colvin M and Hilton J: Pharmacology of cyclophosphamide and metabolites. Cancer Treat Rep 65:89-95, 1981.
7. Brock N, Pohl J and Stekar J: Detoxification of urotoxic oxazaphorines by sulfhydryl compounds. J Cancer Res Clin Oncol 100(3):311-320, 1981. (Pubitemid 11051539)
8. Brock N, Stekar J, Pohl J, et al: Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. Arzneim Forsch 29(4):659-661, 1979. (Pubitemid 9154682)
9. el-Yazigi A, Ernst P, al-Rawithi S, et al: Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation. J Clin Pharmacol 37(7):618-624, 1997.
10. 14C]-mesna in the rat. Arzneim Forsch 36(3):487-489, 1986.